EGFR tyrosine kinase inhibitors (Anhui Normal University)

N/A

Report date: 2025/01/26 17:13:39
NME

Base Information

Drug NameEGFR tyrosine kinase inhibitors (Anhui Normal University)
Drug Alias Name27-O-p-(E)-coumaroyl ursolic acid27-CAUA
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAnhui Normal University
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Normal University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A